+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Chemotherapy At Home Services Market Size, Share & Trends Analysis Report By Product (Oral, Infusion), By Cancer Type (Leukemia, Lung Cancer, Breast Cancer, Colon Cancer, Rectum Cancer), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 168 Pages
  • September 2023
  • Region: Global
  • Grand View Research
  • ID: 5893309
Description Jump to:
The global chemotherapy at home services market size is expected to reach USD 2.63 billion by 2030. It is projected to register a CAGR of 8.28% during the forecast period. The market's growth can be attributed to the increasing shift of patients from hospital to home care settings. Moreover, the lower cost of services compared to hospital settings is expected to boost the demand for the market.

Cancer patients have rapidly adopted technologically advanced or improved chemotherapy devices and telemedicine to benefit from treatment at remote locations with patient safety and convenience. This is expected to boost the growth of the market over the forecast period. Many portable devices have been launched recently to improve the administration of chemotherapy drugs, contributing to the market’s growth. For instance, in March 2022, Shanghai MicroPort Lifesciences Co., Ltd. received marketing approval for “AutoEx Chemotherapy Infusion Pump” from the National Medical Products Administration (NMPA) of China.

The COVID-19 pandemic positively impacted the market owing to increased demand and physicians' promotion of chemotherapy at home services. Moreover, due to the shortage of beds in the hospital settings, companies were focusing on transitioning patients from the hospital to in-home, creating demand for the services. Hence, many service providers launched services to cater to the growing demand for chemotherapy post-pandemic. For instance, in September 2022, Jivika Healthcare launched the ChemoAtHome service in Mumbai to provide access to affordable and high-quality cancer care services to patients.

Chemotherapy At Home Services Report Highlights

  • Based on the product, the oral segment held the largest market share in 2022 owing to the lower cost of the products and the availability of reimbursement for such products in the market
  • Based on the cancer type, leukemia dominated the market in 2022, as chemotherapy is considered one of the primary treatment methods for leukemia patients. The high share of the segment can be due to the high preference for home-based chemotherapy by leukemia patients
  • Based on the region, the North America region held the largest market share in 2022 owing to the growing incidence of cancer in the region, and the rising number of providers offering chemotherapy at home services
  • The market is highly fragmented, with the presence of small-scale businesses offering home-based chemotherapy services. Many companies in developing countries are partnering with cancer treatment centers to offer at home cancer treatment services


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.3.1. Information procurement
1.3.2. Purchased Database
1.3.3. Analyst's internal database
1.3.4. Secondary Sources
1.3.5. Primary Research
1.3.6. Details of Primary Research
1.4. Information or Data Analysis
1.4.1. Data Analysis Models
1.5. 1.5 Market Formulation & Validation
1.5.1. Volume Price Analysis
1.6. List of Secondary Sources
1.7. List of Abbreviations
1.8. Research Objectives
1.8.1. Objective - 1
1.8.2. Objective - 2
1.8.3. Objective - 3
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Dynamics
3.1.1. Market Driver Analysis
3.1.1.1. Increasing incidence of cancer
3.1.1.2. Lower cost of home-based chemotherapy services compared to hospital based services
3.1.1.3. Increasing technological advancements and government initiatives
3.1.2. Market Restraint Analysis
3.1.2.1. Lower reimbursement for chemotherapy at home services
3.1.2.2. Lack of skilled medical staff
3.2. Industry Analysis Tools
3.2.1. Porter's Five Forces Analysis
3.2.2. PESTLE Analysis
3.3. COVID-19 Impact Analysis
Chapter 4. Chemotherapy At Home Services Market: Product Estimates & Trend Analysis
4.1. Segment Definitions
4.2. Chemotherapy At Home Services Market: Product Segment Dashboard
4.3. Chemotherapy At Home Services Market: Product Movement & Market Share Analysis
4.4. Oral
4.4.1. Oral Market, 2018 - 2030 (USD Million)
4.5. Infusion
4.5.1. Infusion Market, 2018 - 2030 (USD Million)
Chapter 5. Chemotherapy At Home Services Market: Cancer Type Estimates & Trend Analysis
5.1. Segment Definitions
5.2. Chemotherapy At Home Services Market: Cancer Type Segment Dashboard
5.3. Chemotherapy At Home Services Market: Cancer Type Movement & Market share Analysis
5.4. Leukemia
5.4.1. Leukemia Market, 2018 - 2030 (USD Million)
5.5. Lung Cancer
5.5.1. Lung Cancer Market, 2018 - 2030 (USD Million)
5.6. Breast Cancer
5.6.1. Breast Cancer Market, 2018 - 2030 (USD Million)
5.7. Colon Cancer
5.7.1. Colon Cancer Market, 2018 - 2030 (USD Million)
5.8. Rectum Cancer
5.8.1. Rectum Cancer Market, 2018 - 2030 (USD Million)
5.9. Cervix Uteri Cancer
5.9.1. Cervix Uteri Cancer Market, 2018 - 2030 (USD Million)
5.10. Prostate Cancer
5.10.1. Prostate Cancer Market, 2018 - 2030 (USD Million)
5.11. Ovarian Cancer
5.11.1. Ovarian Cancer Market, 2018 - 2030 (USD Million)
Chapter 6. Chemotherapy At Home Services Market: Regional Estimates & Trend Analysis
6.1. Chemotherapy At Home Services Market: Regional Movement Analysis, 2022 & 2030
6.2. North America
6.2.1. North America Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. Key Country Dynamics
6.2.2.2. Regulatory Scenario
6.2.2.3. Competitive Scenario
6.2.2.4. U.S. Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Key Country Dynamics
6.2.3.2. Regulatory Scenario
6.2.3.3. Competitive Scenario
6.2.3.4. Canada Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. UK
6.3.2.1. Key Country Dynamics
6.3.2.2. Regulatory Scenario
6.3.2.3. Competitive Scenario
6.3.2.4. U.K. Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Key Country Dynamics
6.3.3.2. Regulatory Scenario
6.3.3.3. Competitive Scenario
6.3.3.4. Germany Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. Key Country Dynamics
6.3.4.2. Regulatory Scenario
6.3.4.3. Competitive Scenario
6.3.4.4. France Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Key Country Dynamics
6.3.5.2. Regulatory Scenario
6.3.5.3. Competitive Scenario
6.3.5.4. Italy Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Key Country Dynamics
6.3.6.2. Regulatory Scenario
6.3.6.3. Competitive Scenario
6.3.6.4. Spain Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Key Country Dynamics
6.3.7.2. Regulatory Scenario
6.3.7.3. Competitive Scenario
6.3.7.4. Denmark Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Key Country Dynamics
6.3.8.2. Regulatory Scenario
6.3.8.3. Competitive Scenario
6.3.8.4. Sweden Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Key Country Dynamics
6.3.9.2. Regulatory Scenario
6.3.9.3. Competitive Scenario
6.3.9.4. Norway Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. Japan
6.4.2.1. Key Country Dynamics
6.4.2.2. Regulatory Scenario
6.4.2.3. Competitive Scenario
6.4.2.4. Japan Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. China
6.4.3.1. Key Country Dynamics
6.4.3.2. Regulatory Scenario
6.4.3.3. Competitive Scenario
6.4.3.4. China Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. Key Country Dynamics
6.4.4.2. Regulatory Scenario
6.4.4.3. Competitive Scenario
6.4.4.4. India Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.5. Australia
6.4.5.1. Key Country Dynamics
6.4.5.2. Regulatory Scenario
6.4.5.3. Competitive Scenario
6.4.5.4. Australia Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.6. Thailand
6.4.6.1. Key Country Dynamics
6.4.6.2. Regulatory Scenario
6.4.6.3. Competitive Scenario
6.4.6.4. Thailand Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.7. South Korea
6.4.7.1. Key Country Dynamics
6.4.7.2. Regulatory Scenario
6.4.7.3. Competitive Scenario
6.4.7.4. South Korea Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Scenario
6.5.2.3. Competitive Scenario
6.5.2.4. Brazil Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key Country Dynamics
6.5.3.2. Regulatory Scenario
6.5.3.3. Competitive Scenario
6.5.3.4. Mexico Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. Argentina
6.5.4.1. Key Country Dynamics
6.5.4.2. Regulatory Scenario
6.5.4.3. Competitive Scenario
6.5.4.4. Argentina Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East & Africa
6.6.1. Middle East & Africa Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. South Africa
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Scenario
6.6.2.3. Competitive Scenario
6.6.2.4. South Africa Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. Saudi Arabia
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Scenario
6.6.3.3. Competitive Scenario
6.6.3.4. Saudi Arabia Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. UAE
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Scenario
6.6.4.3. Competitive Scenario
6.6.4.4. UAE Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Scenario
6.6.5.3. Competitive Scenario
6.6.5.4. Kuwait Chemotherapy At Home Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Profiles
7.1.1. Sciensus Pharma Services Limited
7.1.1.1. Overview
7.1.1.2. Financial Performance
7.1.1.3. Service Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. Portea Medical
7.1.2.1. Overview
7.1.2.2. Financial Performance
7.1.2.3. Service Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. Ubiqare
7.1.3.1. Overview
7.1.3.2. Financial Performance
7.1.3.3. Service Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. Penn Medicine (The Trustees of the University of Pennsylvania)
7.1.4.1. Overview
7.1.4.2. Financial Performance
7.1.4.3. Service Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. Advocate Health Care
7.1.5.1. Overview
7.1.5.2. Financial Performance
7.1.5.3. Service Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. View Health Pty Ltd group (chemo@home Pty Ltd)
7.1.6.1. Overview
7.1.6.2. Financial Performance
7.1.6.3. Service Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. Vitalis Health and Home Care Pty Ltd
7.1.7.1. Overview
7.1.7.2. Financial Performance
7.1.7.3. Service Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. Medibank Private Limited
7.1.8.1. Overview
7.1.8.2. Financial Performance
7.1.8.3. Service Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. TCP Homecare
7.1.9.1. Overview
7.1.9.2. Financial Performance
7.1.9.3. Service Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. LloydsPharmacy Clinical Homecare
7.1.10.1. Overview
7.1.10.2. Financial Performance
7.1.10.3. Service Benchmarking
7.1.10.4. Strategic Initiatives
7.2. Company Categorization
7.3. Company Market Position Analysis
7.4. Strategy Mapping
Chapter 8. Recommendations/Key Market Insights
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 4 Global chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 5 Global chemotherapy at home services market, by region, 2018 - 2030 (USD Million)
Table 6 North America chemotherapy at home services market, by country, 2018 - 2030 (USD Million)
Table 7 North America chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 8 North America chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 9 U.S. chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 10 U.S. chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 11 Canada chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 12 Canada chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 13 Europe chemotherapy at home services market, by country, 2018 - 2030 (USD Million)
Table 14 Europe chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 15 Europe chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 16 UK chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 17 UK chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 18 Germany chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 19 Germany chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 20 France chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 21 France chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 22 Italy chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 23 Italy chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 24 Spain chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 25 Spain chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 26 Denmark chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 27 Denmark chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 28 Sweden chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 29 Sweden chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 30 Norway chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 31 Norway chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 32 Asia Pacific chemotherapy at home services market, by country, 2018 - 2030 (USD Million)
Table 33 Asia Pacific chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 34 Asia Pacific chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 35 Japan chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 36 Japan chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 37 India chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 38 India chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 39 China chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 40 China chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 41 Australia chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 42 Australia chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 43 Thailand chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 44 Thailand chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 45 South Korea chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 46 South Korea chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 47 Latin America chemotherapy at home services market, by country, 2018 - 2030 (USD Million)
Table 48 Latin America chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 49 Latin America chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 50 Brazil chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 51 Brazil chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 52 Mexico chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 53 Mexico chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 54 Argentina chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 55 Argentina chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 56 Middle East & Africa chemotherapy at home services market, by country, 2018 - 2030 (USD Million)
Table 57 Middle East & Africa chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 58 Middle East & Africa chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 59 South Africa chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 60 South Africa chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 61 Saudi Arabia chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 62 Saudi Arabia chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 63 UAE chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 64 UAE chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 65 Kuwait chemotherapy at home services market, by product, 2018 - 2030 (USD Million)
Table 66 Kuwait chemotherapy at home services market, by cancer type, 2018 - 2030 (USD Million)
Table 67 Participant's overview
Table 68 Financial performance
Table 69 Key companies undergoing expansions
Table 70 Key companies undertaking acquisitions
Table 71 Key companies undergoing partnership & collaborations
Table 72 Key companies launching new products
Table 73 Key companies undergoing other strategies
List of Figures
Fig. 1 Chemotherapy At Home Services market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value - chain - based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market product & validation
Fig. 9 Market snapshot
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Chemotherapy at home services market driver analysis
Fig. 13 Chemotherapy at home services market restraint analysis
Fig. 14 Chemotherapy at home services market: Porter's analysis
Fig. 15 Chemotherapy at home services market: PESTLE analysis
Fig. 16 Chemotherapy at home services market: Product outlook and key takeaways
Fig. 17 Chemotherapy at home services market: Product market share and movement analysis, 2022 - 2030
Fig. 18 Global oral market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Global infusion market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Chemotherapy at home services market: Cancer Type outlook and key takeaways
Fig. 21 Chemotherapy at home services market: Cancer Type market share analysis, 2022 - 2030
Fig. 22 Global leukemia market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Global lung cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Global breast cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Global colon cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Global rectum cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Global cervix uteri cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Global prostate cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Global ovarian cancer market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Regional marketplace: Key takeaways
Fig. 31 North America chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 U.S. chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 U.S.: Country dynamics
Fig. 34 Canada chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Canada: Country dynamics
Fig. 36 Europe chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 UK chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 UK: Country dynamics
Fig. 39 Germany chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Germany: Country dynamics
Fig. 41 France chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 France: Country dynamics
Fig. 43 Italy chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Italy: Country dynamics
Fig. 45 Spain chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Spain: Country dynamics
Fig. 47 Denmark chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Denmark: Country dynamics
Fig. 49 Sweden chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Sweden: Country dynamics
Fig. 51 Norway chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Norway: Country dynamics
Fig. 53 Asia - Pacific chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Japan chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Japan: Country dynamics
Fig. 56 China chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 China: Country dynamics
Fig. 58 India chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 India: Country dynamics
Fig. 60 Australia chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Australia: Country dynamics
Fig. 62 Thailand chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 Thailand: Country dynamics
Fig. 64 South Korea chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 South Korea: Country dynamics
Fig. 66 Latin America chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Brazil chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Brazil: Country dynamics
Fig. 69 Mexico chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 Mexico: Country dynamics
Fig. 71 Argentina chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Argentina: Country dynamics
Fig. 73 MEA chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 South Africa chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 South Africa: Country dynamics
Fig. 76 Saudi Arabia chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 77 Saudi Arabia: Country dynamics
Fig. 78 UAE chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 79 UAE: Country dynamics
Fig. 80 Kuwait chemotherapy at home services market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 81 Kuwait: Country dynamics
Fig. 82 Key company categorization
Fig. 83 Company market position analysis
Fig. 84 Market participant categorization
Fig. 85 Strategy framework

Companies Mentioned

  • Sciensus Pharma Services Limited
  • Portea Medical
  • Ubiqare
  • Penn Medicine (The Trustees of the University of Pennsylvania)
  • Advocate Health Care
  • View Health Pty Ltd group (chemo@home Pty Ltd)
  • Vitalis Health and Home Care Pty Ltd
  • Medibank Private Limited
  • TCP Homecare
  • LloydsPharmacy Clinical Homecare

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages168
PublishedSeptember 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 1.39 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.63 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Liver Cancer Drug Market Size, Share & Trends Analysis Report By Drug Class (Targeted Therapy, Immunotherapy, Chemotherapy), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Liver Cancer Drug Market Size, Share & Trends Analysis Report By Drug Class (Targeted Therapy, Immunotherapy, Chemotherapy), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 92 Pages
  • Global
From
Global Liver Metastases Treatment Market Size, Share & Trends Analysis Report by Treatment Type (Chemotherapy, Immunotherapy), Primary Cancer, Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Liver Metastases Treatment Market Size, Share & Trends Analysis Report by Treatment Type (Chemotherapy, Immunotherapy), Primary Cancer, Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • 100 Pages
  • Global
From
Global Gastric Cancer Drugs Market by Molecule Type (Biologics, Small Molecules), Lines of Chemotherapy (First-line Chemotherapy, Second-line Chemotherapy), Route of Administration - Forecast 2024-2030 - Product Image

Global Gastric Cancer Drugs Market by Molecule Type (Biologics, Small Molecules), Lines of Chemotherapy (First-line Chemotherapy, Second-line Chemotherapy), Route of Administration - Forecast 2024-2030

  • Report
  • 195 Pages
  • Global
From
Global Sarcoma Drugs Market by Indication (Angiosarcoma, Chondrosarcoma, Dermatofibrosarcoma Protuberans), Drugs (Chemotherapy Drugs, Immunotherapy Drugs, Targeted Drug Therapy), Sales Channel, End-User - Forecast 2024-2030 - Product Image

Global Sarcoma Drugs Market by Indication (Angiosarcoma, Chondrosarcoma, Dermatofibrosarcoma Protuberans), Drugs (Chemotherapy Drugs, Immunotherapy Drugs, Targeted Drug Therapy), Sales Channel, End-User - Forecast 2024-2030

  • Report
  • 195 Pages
  • Global
From
Chemotherapy Market - Global Industry Size, Share, Trends, Opportunities and Forecast, 2018-2028 - Product Image

Chemotherapy Market - Global Industry Size, Share, Trends, Opportunities and Forecast, 2018-2028

  • Report
  • 190 Pages
  • Global
From

About the Home Chemotherapy Market

Home chemotherapy is a form of oncology drug delivery that allows patients to receive their medication in the comfort of their own home. This type of treatment is becoming increasingly popular as it allows patients to receive their medication without having to travel to a hospital or clinic. Home chemotherapy is typically administered by a healthcare professional, such as a nurse, who visits the patient's home to provide the medication. This type of treatment is often used for patients with chronic or advanced cancer, as it allows them to receive their medication in a more comfortable and convenient setting. Home chemotherapy can also be beneficial for patients who are unable to travel to a hospital or clinic due to physical or mental health issues. This type of treatment can also help reduce the cost of care, as it eliminates the need for hospital visits and other associated costs. Some companies in the home chemotherapy market include Baxalta, Amgen, and Novartis. These companies provide a range of oncology drugs that can be administered at home. Additionally, there are a number of other companies that provide home chemotherapy services, such as CVS Health, Walgreens, and Express Scripts. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.